Relieves muscle spasm associated with acute, painful musculoskeletal conditions. ANDA 71611, held by Actavis Laboratories FL. Cyclobenzaprine Hydrochloride.
As of Nov 21, 2026, ANDA 71611 (Cyclobenzaprine Hydrochloride), held by Actavis Laboratories FL, was first approved by FDA on Feb 29, 1988, with 33 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Cyclobenzaprine HCl is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 29, 1988 | Original application | Approved | None posted |
| Cyclobenzaprine Hydrochloride10MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Cyclobenzaprine Hydrochloride5MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Cyclobenzaprine Hydrochloride7.5MG · tablet;oral | Cyclobenzaprine Hydrochloride | Rx |
| Jul 30, 2013 | Supplement 70Labeling · Standard review | Approved | None posted |
| Apr 11, 2013 | Supplement 69Labeling · Standard review | Approved | None posted |
| Sep 24, 2012 | Supplement 67Manufacturing | Approved | None posted |
| Feb 3, 2006 | Supplement 40Manufacturing | Approved | None posted |
| Feb 3, 2006 | Supplement 39Labeling | Approved | None posted |
| Feb 3, 2006 | Supplement 38Manufacturing | Approved | None posted |
| Apr 25, 2001 | Supplement 34Manufacturing | Approved | None posted |
| Dec 29, 2000 | Supplement 33Manufacturing | Approved | None posted |
| Dec 23, 1998 | Supplement 30Manufacturing | Approved | None posted |
| Aug 15, 1996 | Supplement 29Manufacturing | Approved | None posted |
| Aug 15, 1996 | Supplement 28Manufacturing | Approved | None posted |
| Aug 15, 1996 | Supplement 27Manufacturing | Approved | None posted |
| Aug 15, 1996 | Supplement 26Manufacturing | Approved | None posted |
| Aug 15, 1996 | Supplement 25Manufacturing | Approved | None posted |
| Aug 15, 1996 | Supplement 24Manufacturing | Approved | None posted |
| Dec 20, 1993 | Supplement 23Manufacturing | Approved | None posted |
| Jun 29, 1993 | Supplement 22Labeling | Approved | None posted |
| Mar 12, 1993 | Supplement 18Labeling | Approved | None posted |
| Mar 12, 1993 | Supplement 17Manufacturing | Approved | None posted |
| Sep 29, 1992 | Supplement 16Manufacturing | Approved | None posted |
| Sep 29, 1992 | Supplement 15Manufacturing | Approved | None posted |
| Sep 29, 1992 | Supplement 14Manufacturing | Approved | None posted |
| May 31, 1991 | Supplement 11Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 13Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 8Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 7Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 5Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 4Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 3Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 2Manufacturing | Approved | None posted |
| Jan 28, 1991 | Supplement 12Manufacturing | Approved | None posted |
| Feb 22, 1990 | Supplement 10Manufacturing | Approved | None posted |
| Apr 20, 1989 | Supplement 1Manufacturing | Approved | None posted |
| Feb 29, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters